Butyphthalide in Combination With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT03394950
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Hui-Sheng Chen
- Registry
-
NCT03394950
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03394950. Randomized; double masking; primary purpose prevention. Start 2018-05-25 (actual); primary completion 2021-05-29 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Butyphthalide in Combination With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
- Condition
- Stroke, Ischemic
- Intervention (Drug)
- Butyphthalide combined with rtPA
- Intervention (Drug)
- rtPA
- Lead sponsor
- Hui-Sheng Chen
Record details
- Record id
cardio:ct-nct03394950- Content hash
bcdf0c6f74af857a7686fd5320974569d525f4f3bb59ca450f4faa1fbb4bc661